التفاصيل البيبلوغرافية
| العنوان: |
Cardiopreventive capacity of a novel (E)‐Nʹ‐(1‐(7‐methoxy‐2‐oxo‐2H‐chromen‐3‐yl) ethylidene)‐4‐methylbenzenesulfonohydrazide against isoproterenol‐induced myocardial infarction by moderating biochemical, oxidative stress, and histological parameters |
| المؤلفون: |
Khdhiri, Emna, Mnafgui, Kais, Ncir, Marwa, Feriani, Anouar, Ghazouani, Lakhdar, Hajji, Raouf, Jallouli, Dana, Abid, Majdi, Jamoussi, Kamel, Allouche, Noureddine, Ammar, Houcine, Abid, Souhir |
| المصدر: |
Journal of Biochemical & Molecular Toxicology; Jun2021, Vol. 35 Issue 6, p1-13, 13p |
| مصطلحات موضوعية: |
MYOCARDIAL infarction, OXIDATIVE stress, CHOLESTEROL content of food, ELLAGIC acid, OVERHAUSER effect (Nuclear physics), LABORATORY rats, LACTATE dehydrogenase, SUPEROXIDES |
| مستخلص: |
This study is carried out to assess the cardiopreventive effect of (E)‐N'‐(1‐(7‐methoxy‐2‐oxo‐2H‐chromen‐3‐yl) ethylidene)‐4‐methylbenzenesulfonohydrazide or SHC, a novel synthesized coumarin, against myocardial infarction induced by isoproterenol (ISO). The SHC compound was identified and characterized by spectral methods (infrared, 1H NMR [nuclear magnetic resonance], 13C NMR, Nuclear Overhauser Effect Spectroscopy, and high‐resolution mass spectroscopy). Male Wistar rats were divided into four groups: Control, ISO (rats were injected subcutaneously by 85 mg/kg body weight [BW] of isoproterenol at Days 6 and 7 of the experience), ISO + SHC (150 µg/kg BW, orally for 7 days) and ISO + acenocoumarol (150 µg/kg BW, orally for 7 days). Results showed that ISO induced a remarkable alteration of electrocardiogram (ECG) pattern and increases of plasma cardiac troponin T, creatine kinase‐MB, total cholesterol, triglycerides, low‐density lipoprotein‐cholesterol, lactate dehydrogenase, aspartate transaminase, and malondialdehyde. In addition, ISO reduced the high‐density lipoprotein‐cholesterol content and the activities of superoxide dismutase and glutathione peroxidase, with the induction of myocardial necrosis. However, SHC administration revealed a significant decrease in cardiac dysfunction markers, restored normal ECG pattern, as well as improving lipids parameters. Moreover, SHC treatment remarkably alleviated the cardiac oxidative stress and the myocardial remodeling process. Overall, the SHC offers good protection from acute myocardial infarction through the antioxidant capacity. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Biochemical & Molecular Toxicology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
